SHELBIE MANNA: Open Payments
NPI 1629683586 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 10 payments from 5 companies in 2025. Trend: 2023 $102 · 2024 $476 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $218 |
| Novo Nordisk Inc | 2 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| Celltrion USA Inc. | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $19 |
Products named: REZDIFFRA, Wegovy, ENTYVIO, VEGZELMA.
Industry payments across FL — which companies pay providers there.
